Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of mineralocorticoid receptor stimulation on cognitive bias and social cognition in major depression and healthy controls
2014-005239-15Phase 2Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Feb 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fludrocortisone in major depressive disorder (MDD), sponsored by Charité – Universitätsmedizin Berlin. Started Feb 2016; status: completed.
02
Drugs
fludrocortisone
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2014-005239-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005239-15.